Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


15 - 17 May 2018
The Hotel Brussels,

Critical guidance on competition law, patent litigation, regulatory frameworks, compliance and licensing agreements

Thank you for attending the 2017 event-check back soon for more details about 2018!

Europe's leading pharmaceutical law conference-What questions were answered at the 2017 event?

Competition Law & Patent Litigation
  • EU Commission keynote: feedback on competition law
  • Lundbeck case: lessons learnt on reverse payment pattern settlements and implications for industry
  • Dominance through excessive pricing: current status and new case law
  • SPCs: analysis and current shortcomings of the regulation

Regulatory Frameworks
  • EMA and European Commission keynotes on the regulatory landscape
  • An update on regulatory IP rights: Orphan drug and paediatric exclusivity and RDP
  • EU Clinical Trials Regulation: examine implementation requirements and assess the impact of Brexit
  • Pharmaceutical marketing: Promotions, advertising and digital media - what are the legal challenges?
Compliance: Data Privacy & Anti-Bribery
  • EU General Data Protection Regulation: obligations and sanctions for non-compliance 
  • Exploring current privacy policies to ensure alignment with new requirements including mobile apps and e-health
  • Clarity on transparency: what is the status and where will it be in the future?
  • Anti-bribery: conducting an internal investigation and examining the legal challenges
Licensing & Collaboration Agreements
  • Deal structuring: examine the increasingly innovative nature and associated challenges
  • Antitrust implications of licensing and collaboration: in-house and private practice feedback
  • Early stage clinical licensing deals: potential pitfalls and how to avoid them
  • Due diligence: Licensing options and IP considerations
Brexit and the Impact on the Industry

The UK's exit from the EU will have a significant impact on pharmaceutical law. Hear Europe's leading experts debate and discuss Brexit's impact on key areas including:

  • SPC regulations
  • Regulatory IP rights
  • Unified Patent Court
  • Regulatory Frameworks
Implementing the European Medical Device Regulations

Join your peers at our evening seminar and dinner as our expert speakers examine the new European Medical Device Regulations and the impact on industry

  • Assess the transitional provisions for implementing the Regulations: implementing the delegated acts
  • Understand the increased obligations on economic operators
  • Examine the rules on liability and transparency
  • Classification of products: what is the current state of play?

Who was there?

Partners, Lawyers, Attorneys, In-House Counsel, Compliance Officers and Licensing Counsel
Leading industry companies including Pfizer, J&J, Novartis, Novo Nordisk, Astellas and many more
Influential speakers provide critical feedback on high profile case law.